Comprehensive Advances in In-Situ Hybridization Techniques Driving Molecular Diagnostics Forward In-situ hybridization (ISH) has emerged as a pivotal molecular biology tool that enables precise localization of specific nucleic acid sequences within cells and tissue sections. This advanced cytogenetic technique combines molecular biology with histology, facilitating the visualization of RNA or DNA sequences directly in the structural context of the tissue. Widely employed in research and clinical diagnostics, ISH is transforming the landscape of genetic analysis, disease diagnosis, and personalized medicine. Understanding the Fundamental Mechanism and Applications of In-Situ Hybridization In-Situ Hybridization operates by hybridizing a labeled complementary DNA or RNA probe to target nucleotide sequences within fixed cells or tissue samples. These probes can be tagged with fluorescent dyes, radioactive isotopes, or enzymatic labels, allowing researchers and clinicians to detect specific mRNA or DNA sequences visually under a microscope. The high spatial resolution of ISH enables identification of gene expression patterns, chromosomal aberrations, and infectious agents at a cellular level without disrupting tissue architecture. In-Situ Hybridization-https://www.coherentmarketinsights.com/market-insight/in-situ-hybridization-market-2057